vs
Side-by-side financial comparison of Royalty Pharma plc (RPRX) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $324.4M, roughly 1.9× Revolve Group, Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 5.7%, a 28.7% gap on every dollar of revenue. On growth, Revolve Group, Inc. posted the faster year-over-year revenue change (10.4% vs 4.8%). Over the past eight quarters, Revolve Group, Inc.'s revenue compounded faster (9.5% CAGR vs 4.6%).
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
RPRX vs RVLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $622.0M | $324.4M |
| Net Profit | $214.2M | $18.6M |
| Gross Margin | — | 53.3% |
| Operating Margin | 62.4% | 6.3% |
| Net Margin | 34.4% | 5.7% |
| Revenue YoY | 4.8% | 10.4% |
| Net Profit YoY | 2.9% | 50.4% |
| EPS (diluted) | $0.49 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $622.0M | $324.4M | ||
| Q3 25 | $609.3M | $295.6M | ||
| Q2 25 | $578.7M | $309.0M | ||
| Q1 25 | $568.2M | $296.7M | ||
| Q4 24 | $593.6M | $293.7M | ||
| Q3 24 | $564.7M | $283.1M | ||
| Q2 24 | $537.3M | $282.5M | ||
| Q1 24 | $568.0M | $270.6M |
| Q4 25 | $214.2M | $18.6M | ||
| Q3 25 | $288.2M | $21.2M | ||
| Q2 25 | $30.2M | $10.2M | ||
| Q1 25 | $238.3M | $11.8M | ||
| Q4 24 | $208.2M | $12.3M | ||
| Q3 24 | $544.0M | $11.0M | ||
| Q2 24 | $102.0M | $15.4M | ||
| Q1 24 | $4.8M | $10.9M |
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
| Q4 25 | 62.4% | 6.3% | ||
| Q3 25 | 70.1% | 7.1% | ||
| Q2 25 | 36.3% | 5.8% | ||
| Q1 25 | 94.0% | 5.0% | ||
| Q4 24 | 60.9% | 3.9% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | 50.2% | 5.8% | ||
| Q1 24 | -13.0% | 3.4% |
| Q4 25 | 34.4% | 5.7% | ||
| Q3 25 | 47.3% | 7.2% | ||
| Q2 25 | 5.2% | 3.3% | ||
| Q1 25 | 41.9% | 4.0% | ||
| Q4 24 | 35.1% | 4.2% | ||
| Q3 24 | 96.3% | 3.9% | ||
| Q2 24 | 19.0% | 5.4% | ||
| Q1 24 | 0.8% | 4.0% |
| Q4 25 | $0.49 | $0.27 | ||
| Q3 25 | $0.67 | $0.29 | ||
| Q2 25 | $0.07 | $0.14 | ||
| Q1 25 | $0.55 | $0.16 | ||
| Q4 24 | $0.46 | $0.18 | ||
| Q3 24 | $1.21 | $0.15 | ||
| Q2 24 | $0.23 | $0.21 | ||
| Q1 24 | $0.01 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $618.7M | $292.3M |
| Total DebtLower is stronger | $9.0B | — |
| Stockholders' EquityBook value | $9.7B | $512.5M |
| Total Assets | $19.6B | $765.0M |
| Debt / EquityLower = less leverage | 0.92× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $618.7M | $292.3M | ||
| Q3 25 | $938.9M | $315.4M | ||
| Q2 25 | $631.9M | $310.7M | ||
| Q1 25 | $1.1B | $300.8M | ||
| Q4 24 | $929.0M | $256.6M | ||
| Q3 24 | $950.1M | $252.8M | ||
| Q2 24 | $1.8B | $244.7M | ||
| Q1 24 | $843.0M | $273.4M |
| Q4 25 | $9.0B | — | ||
| Q3 25 | $8.9B | — | ||
| Q2 25 | $8.0B | — | ||
| Q1 25 | $7.6B | — | ||
| Q4 24 | $7.6B | — | ||
| Q3 24 | $7.6B | — | ||
| Q2 24 | $7.6B | — | ||
| Q1 24 | $6.1B | — |
| Q4 25 | $9.7B | $512.5M | ||
| Q3 25 | $9.6B | $490.2M | ||
| Q2 25 | $9.5B | $468.6M | ||
| Q1 25 | $9.8B | $453.4M | ||
| Q4 24 | $10.3B | $437.8M | ||
| Q3 24 | $10.3B | $420.8M | ||
| Q2 24 | $9.8B | $405.8M | ||
| Q1 24 | $9.9B | $389.9M |
| Q4 25 | $19.6B | $765.0M | ||
| Q3 25 | $19.3B | $751.3M | ||
| Q2 25 | $18.3B | $722.9M | ||
| Q1 25 | $17.6B | $713.9M | ||
| Q4 24 | $18.2B | $665.5M | ||
| Q3 24 | $18.0B | $670.9M | ||
| Q2 24 | $17.7B | $657.8M | ||
| Q1 24 | $16.1B | $650.0M |
| Q4 25 | 0.92× | — | ||
| Q3 25 | 0.93× | — | ||
| Q2 25 | 0.84× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $827.1M | $-10.2M |
| Free Cash FlowOCF − Capex | — | $-13.3M |
| FCF MarginFCF / Revenue | — | -4.1% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | 3.86× | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $827.1M | $-10.2M | ||
| Q3 25 | $702.6M | $11.8M | ||
| Q2 25 | $364.0M | $12.6M | ||
| Q1 25 | $596.1M | $45.1M | ||
| Q4 24 | $742.5M | $3.9M | ||
| Q3 24 | $703.6M | $9.1M | ||
| Q2 24 | $658.2M | $-24.7M | ||
| Q1 24 | $664.6M | $38.4M |
| Q4 25 | — | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $8.0M | ||
| Q2 24 | — | $-25.7M | ||
| Q1 24 | — | $36.7M |
| Q4 25 | — | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 3.86× | -0.55× | ||
| Q3 25 | 2.44× | 0.56× | ||
| Q2 25 | 12.06× | 1.24× | ||
| Q1 25 | 2.50× | 3.82× | ||
| Q4 24 | 3.57× | 0.32× | ||
| Q3 24 | 1.29× | 0.83× | ||
| Q2 24 | 6.45× | -1.60× | ||
| Q1 24 | 139.10× | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
